{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:28:37Z","timestamp":1782793717527,"version":"3.54.5"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.intimp.2025.114486","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T13:34:12Z","timestamp":1742391252000},"page":"114486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Nebivolol rescued the liver and kidney from the coadministration of rivaroxaban and cisplatin by targeting inflammation, oxidative stress, and apoptosis in rats"],"prefix":"10.1016","volume":"153","author":[{"given":"Ahmed M.","family":"Abd-Eldayem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa F.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esraa A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.114486_bb0005","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.arcmed.2015.08.005","article-title":"Protective effects of apocynin on cisplatin-induced hepatotoxicity in rats","volume":"46","author":"Cagin","year":"2015","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.intimp.2025.114486_bb0010","series-title":"Analysis of the Therapeutic Role of Platelet - Rich Plasma Against Cisplatin - Induced Hepatotoxicity in rats\u00a0: Controversy Between Oxidative and Apoptotic Markers","first-page":"201","volume":"23","author":"El Sharouny","year":"2019"},{"key":"10.1016\/j.intimp.2025.114486_bb0015","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/hep.23917","article-title":"The role of intestinal endotoxin in liver injury: a long and evolving history","volume":"52","author":"Nolan","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2025.114486_bb0020","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.intimp.2018.06.008","article-title":"Protective effects of ginsenoside Rg1 against lipopolysaccharide\/d-galactosamine-induced acute liver injury in mice through inhibiting toll-like receptor 4 signaling pathway","volume":"61","author":"Ning","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114486_bb0025","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10157-024-02490-x","article-title":"An integrated view of cisplatin-induced nephrotoxicity, hepatotoxicity, and cardiotoxicity: characteristics, common molecular mechanisms, and current clinical management","volume":"28","author":"Oliveira","year":"2024","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.intimp.2025.114486_bb0030","article-title":"Arbutin abrogates cisplatin-induced hepatotoxicity via upregulating Nrf2\/HO-1 and suppressing genotoxicity, NF-\u03baB\/iNOS\/TNF-\u03b1 and caspase-3\/Bax\/Bcl2 signaling pathways in rats","volume":"13","author":"Okkay","year":"2024","journal-title":"Toxicol. Res. (Camb)"},{"key":"10.1016\/j.intimp.2025.114486_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151649","article-title":"Tangeretin alleviates cisplatin-induced acute hepatic injury in rats: targeting MAPKs and apoptosis","volume":"11","author":"Omar","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2025.114486_bb0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2018.03.009","article-title":"Cisplatin-induced gastrointestinal toxicity: An update on possible mechanisms and on available gastroprotective strategies","volume":"827","author":"Shahid","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114486_bb0045","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114486_bb0050","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1089\/ars.2009.3074","article-title":"Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders","volume":"13","author":"Calabrese","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.intimp.2025.114486_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107925","article-title":"Betulin alleviates cisplatin-induced hepatic injury in rats: targeting apoptosis and Nek7-independent NLRP3 inflammasome pathways","volume":"99","author":"Eisa","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114486_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.563750","article-title":"Licorice ameliorates cisplatin-induced hepatotoxicity through Antiapoptosis, Antioxidative stress, anti-inflammation, and acceleration of metabolism","volume":"11","author":"Man","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114486_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173168","article-title":"A novel effect of Aprepitant: protection for cisplatin-induced nephrotoxicity and hepatotoxicity","volume":"880","author":"Un","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114486_bb0070","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.010884","article-title":"In-depth identification of pathways related to cisplatin-induced hepatotoxicity through an integrative method based on an informatics-assisted label-free protein quantitation and microarray gene expression approach","volume":"11","author":"Cho","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.intimp.2025.114486_bb0075","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0022-3565(24)36493-6","article-title":"Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain","volume":"280","author":"Kruidering","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2025.114486_bb0080","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00580-021-03252-x","article-title":"Abrogation of cisplatin-induced nephrotoxicity in rats and HEK-293 cell lines by formononetin: in vivo and in vitro study","volume":"30","author":"Shinde","year":"2021","journal-title":"Comp. Clin. Pathol."},{"key":"10.1016\/j.intimp.2025.114486_bb0085","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.tox.2011.04.014","article-title":"Protective effect of sulforaphane pretreatment against cisplatin-induced liver and mitochondrial oxidant damage in rats","volume":"286","author":"Gaona-Gaona","year":"2011","journal-title":"Toxicology"},{"key":"10.1016\/j.intimp.2025.114486_bb0090","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ki.2012.199","article-title":"Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats","volume":"82","author":"Humanes","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2025.114486_bb0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tox.2008.12.017","article-title":"Sildenafil attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity","volume":"257","author":"Lee","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.intimp.2025.114486_bb0100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MAJ.0b013e31812dfe1e","article-title":"Cisplatin nephrotoxicity: a review","volume":"334","author":"Yao","year":"2007","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.intimp.2025.114486_bb0105","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2025.114486_bb0110","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1046\/j.1523-1755.2001.00026.x","article-title":"Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells","volume":"60","author":"Kaushal","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2025.114486_bb0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1742-7843.2005.pto_114.x","article-title":"Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide","volume":"97","author":"Saleh","year":"2005","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.intimp.2025.114486_bb0120","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.intimp.2025.114486_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119224","article-title":"Vincamine protects against cisplatin induced nephrotoxicity via activation of Nrf2\/HO-1 and hindering TLR4\/ IFN-\u03b3\/CD44 cells inflammatory cascade","volume":"272","author":"El-Sayed","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2025.114486_bb0130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.fct.2017.10.006","article-title":"Supplementation of American ginseng berry extract mitigated cisplatin-evoked nephrotoxicity by suppressing ROS-mediated activation of MAPK and NF-\u03baB signaling pathways","volume":"110","author":"Ma","year":"2017","journal-title":"Food Chem. Toxicol. an Int. J. Publ. Br. Ind. Biol. Res. Assoc."},{"key":"10.1016\/j.intimp.2025.114486_bb0135","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archinte.164.2.190","article-title":"Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon","volume":"164","author":"Otten","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.intimp.2025.114486_bb0140","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.intimp.2025.114486_bb0145","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1592\/phco.22.13.1200.33524","article-title":"Recurrent peripheral arterial thrombosis induced by cisplatin and etoposide","volume":"22","author":"Cool","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.intimp.2025.114486_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/sca.4950230101","article-title":"Antithrombotic treatment in protection against thrombogenic effects of 5-fluorouracil on vascular endothelium: a scanning microscopy evaluation","volume":"23","author":"Kinhult","year":"2001","journal-title":"Scanning"},{"key":"10.1016\/j.intimp.2025.114486_bb0155","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/10428199909058436","article-title":"Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L-asparaginase","volume":"33","author":"Oner","year":"1999","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.intimp.2025.114486_bb0160","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1200\/JCO.1988.6.2.276","article-title":"Chemotherapy for breast cancer decreases plasma protein C and protein S","volume":"6","author":"Rogers","year":"1988","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.intimp.2025.114486_bb0165","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/1097-0142(197710)40:4<1398::AID-CNCR2820400406>3.0.CO;2-#","article-title":"The effect of L-asparaginase of plasma coagulation factors in acute lymphoblastic leukemia","volume":"40","author":"Ramsay","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.intimp.2025.114486_bb0170","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1001\/archinte.1996.00440150056006","article-title":"Effect of tamoxifen on measurements of hemostasis in healthy women","volume":"156","author":"Mannucci","year":"1996","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.intimp.2025.114486_bb0175","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1365-2141.2001.03095.x","article-title":"Thrombogenic role of cells undergoing apoptosis","volume":"115","author":"Wang","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.intimp.2025.114486_bb0180","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.thromres.2005.10.015","article-title":"Chemotherapy-induced thrombosis","volume":"118","author":"Haddad","year":"2006","journal-title":"Thromb. Res."},{"key":"10.1016\/j.intimp.2025.114486_bb0185","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1158\/1078-0432.CCR-0734-04","article-title":"The effects of standard anthracycline-based chemotherapy on soluble ICAM-1 and vascular endothelial growth factor levels in breast cancer","volume":"10","author":"Mills","year":"2004","journal-title":"Clin. Cancer Res. An Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.intimp.2025.114486_bb0190","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2141.1992.tb02978.x","article-title":"Modulation of tissue factor on human monocytes by cisplatin and adriamycin","volume":"81","author":"Walsh","year":"1992","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.intimp.2025.114486_bb0195","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0049-3848(00)00294-2","article-title":"Cisplatin triggers platelet activation","volume":"99","author":"Togna","year":"2000","journal-title":"Thromb. Res."},{"key":"10.1016\/j.intimp.2025.114486_bb0200","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000226049","article-title":"Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy","volume":"42","author":"Licciardello","year":"1985","journal-title":"Oncology"},{"key":"10.1016\/j.intimp.2025.114486_bb0205","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijscr.2017.11.007","article-title":"Cisplatin induced acute mesenteric ischaemia: A case report and review of the literature","volume":"41","author":"Khosla","year":"2017","journal-title":"Int. J. Surg. Case Rep."},{"key":"10.1016\/j.intimp.2025.114486_bb0210","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000024695","article-title":"D-dimer can be a diagnostic marker for cisplatin-related aortic thrombosis: A case report","volume":"100","author":"Matsumoto","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.intimp.2025.114486_bb0215","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejca.2016.10.003","article-title":"Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours","volume":"69","author":"Gizzi","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.intimp.2025.114486_bb0220","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/MEG.0000000000001030","article-title":"Rivaroxaban-induced hepatotoxicity: review of the literature and report of new cases","volume":"30","author":"Licata","year":"2018","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2025.114486_bb0225","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s11239-016-1429-1","article-title":"Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study","volume":"43","author":"Mantha","year":"2017","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.intimp.2025.114486_bb0230","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1160\/TH17-03-0171","article-title":"Rivaroxaban for preventing venous thromboembolism in high-risk ambulatory patients with cancer: rationale and design of the CASSINI trial. Rationale and design of the CASSINI trial","volume":"117","author":"Khorana","year":"2017","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.intimp.2025.114486_bb0235","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"Danan","year":"1993","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.intimp.2025.114486_bb0240","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/11586600-000000000-00000","article-title":"Evaluation of drug-induced serious hepatotoxicity (eDISH): application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgery","volume":"34","author":"Watkins","year":"2011","journal-title":"Drug Saf."},{"key":"10.1016\/j.intimp.2025.114486_bb0245","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s40264-015-0317-5","article-title":"Hepatotoxicity of new Oral anticoagulants (NOACs)","volume":"38","author":"Liakoni","year":"2015","journal-title":"Drug Saf."},{"key":"10.1016\/j.intimp.2025.114486_bb0250","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jhep.2014.03.026","article-title":"Rivaroxaban postmarketing risk of liver injury","volume":"61","author":"Russmann","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2025.114486_bb0255","doi-asserted-by":"crossref","first-page":"S1268","DOI":"10.14309\/00000434-201810001-02233","article-title":"Rivaroxaban-induced liver injury: A rare event or the tip of an iceberg?","volume":"113","author":"Shah","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.intimp.2025.114486_bb0260","doi-asserted-by":"crossref","first-page":"878","DOI":"10.14309\/ajg.0000000000001259","article-title":"ACG clinical guideline: diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury","volume":"116","author":"Chalasani","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.intimp.2025.114486_bb0265","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1517\/14656560903413559","article-title":"Rivaroxaban, the first oral, direct factor Xa inhibitor","volume":"10","author":"Fassiadis","year":"2009","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.intimp.2025.114486_bb0270","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.12659\/AJCR.917492","article-title":"Rivaroxaban-induced acute interstitial nephritis: A case report","volume":"20","author":"Zafar","year":"2019","journal-title":"Am. J. Case Rep."},{"key":"10.1016\/j.intimp.2025.114486_bb0275","article-title":"Rivaroxaban-related acute kidney injury in a patient with IgA vasculitis","volume":"12","author":"Fujino","year":"2019","journal-title":"BMJ Case Reports CP."},{"key":"10.1016\/j.intimp.2025.114486_bb0280","first-page":"212","article-title":"Case report: rivaroxaban related nephropathy","volume":"31","author":"Costa","year":"2022","journal-title":"J. Nephropathol."},{"key":"10.1016\/j.intimp.2025.114486_bb0285","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012195","article-title":"Rivaroxaban, a direct factor Xa inhibitor, ameliorates hypertensive renal damage through inhibition of the inflammatory response mediated by protease-activated receptor pathway","volume":"8","author":"Ichikawa","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.intimp.2025.114486_bb0290","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/ehjqcco\/qcz047","article-title":"Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes","volume":"6","author":"Hernandez","year":"2020","journal-title":"Eur. Hear. J. - Qual. Care Clin. Outcomes."},{"key":"10.1016\/j.intimp.2025.114486_bb0295","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/01.CIR.102.6.677","article-title":"Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta(2)-adrenergic receptor-mediated nitric oxide production","volume":"102","author":"Broeders","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2025.114486_bb0300","series-title":"Nebivolol Induces Nitric Oxide Release in the Heart through Inducible Nitric Oxide Synthase Activation., Hypertens","first-page":"652","volume":"vol. 50","author":"Maffei","year":"1979"},{"key":"10.1016\/j.intimp.2025.114486_bb0305","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2147\/vhrm.2006.2.3.303","article-title":"Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatation","volume":"2","author":"Weiss","year":"2006","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.intimp.2025.114486_bb0310","first-page":"647","article-title":"Nebivolol in the treatment of chronic heart failure","volume":"3","author":"Veverka","year":"2007","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.intimp.2025.114486_bb0315","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/VHRM.S3056","article-title":"Arterial stiffness, hypertension, and rational use of nebivolol","volume":"5","author":"Agabiti-Rosei","year":"2009","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.intimp.2025.114486_bb0320","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/1753944709104496","article-title":"Nitric oxide mechanisms of nebivolol","volume":"3","author":"Maffei","year":"2009","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"10.1016\/j.intimp.2025.114486_bb0325","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12012-020-09614-1","article-title":"Nebivolol prevents up-regulation of Nox2\/NADPH oxidase and Lipoperoxidation in the early stages of ethanol-induced cardiac toxicity","volume":"21","author":"do Vale","year":"2021","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.intimp.2025.114486_bb0330","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1080\/01480545.2021.1908759","article-title":"Nebivolol alleviates liver damage caused by methotrexate via AKT1\/Hif1\u03b1\/eNOS signaling","volume":"45","author":"Pekg\u00f6z","year":"2022","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.intimp.2025.114486_bb0335","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.etap.2018.01.011","article-title":"Protective role of nebivolol in cadmium-induced hepatotoxicity via downregulation of oxidative stress, apoptosis and inflammatory pathways","volume":"58","author":"Refaie","year":"2018","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114486_bb0340","first-page":"375","article-title":"Effect of nebivolol on liver regeneration in an experimental 70% partial hepatectomy model, Asian","volume":"40","author":"Sumer","year":"2017","journal-title":"J. Dermatol. Surg."},{"key":"10.1016\/j.intimp.2025.114486_bb0345","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/1440-1681.13481","article-title":"Nebivolol protects against cyclophosphamide-induced nephrotoxicity through modulation of oxidative stress, inflammation, and apoptosis","volume":"48","author":"Wanas","year":"2021","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.intimp.2025.114486_bb0350","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s43440-020-00059-5","article-title":"Renal protective effect of nebivolol in rat models of acute renal injury: role of sodium glucose co-transporter 2","volume":"72","author":"Nasr","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.intimp.2025.114486_bb0355","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/1440-1681.13001","article-title":"Nebivolol ameliorated kidney damage in Zucker diabetic fatty rats by regulation of oxidative stress\/NO pathway: comparison with captopril","volume":"45","author":"Wang","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.intimp.2025.114486_bb0360","first-page":"718","article-title":"Protective effect of nebivolol on gentamicin-induced nephrotoxicity in rats","volume":"119","author":"Dursun","year":"2018","journal-title":"Bratisl. Lek. Listy"},{"key":"10.1016\/j.intimp.2025.114486_bb0365","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/bcpt.12538","article-title":"Nebivolol ameliorates cisplatin-induced nephrotoxicity in rats","volume":"118","author":"Morsy","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.intimp.2025.114486_bb0370","first-page":"880","article-title":"Protective effects of the third generation vasodilatory \u03b2eta - blocker nebivolol against D-galactosamine - induced hepatorenal syndrome in rats., open access maced","volume":"5","author":"Atwa","year":"2017","journal-title":"J. Med. Sci."},{"key":"10.1016\/j.intimp.2025.114486_bb0375","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/hep.29084","article-title":"The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells","volume":"65","author":"Vilaseca","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2025.114486_bb0380","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.intimp.2025.114486_bb0385","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/niox.2000.0319","article-title":"A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite","volume":"5","author":"Miranda","year":"2001","journal-title":"Nitric Oxide Biol. Chem."},{"key":"10.1016\/j.intimp.2025.114486_bb0390","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.intimp.2025.114486_bb0395","article-title":"Bancroft\u2019s theory and practice of histological techniques","author":"Bancroft","year":"2019","journal-title":"Elsevier"},{"key":"10.1016\/j.intimp.2025.114486_bb0400","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4314\/wsa.v36i4.58409","article-title":"The use of liver histopathology, lipid peroxidation and acetylcholinesterase assays as biomarkers of contaminantinduced stress in the cape stumpnose, rhabdosargus holubi (teleostei: Sparidae), from selected south african estuaries","volume":"36","author":"Richardson","year":"2010","journal-title":"Water SA"},{"key":"10.1016\/j.intimp.2025.114486_bb0405","first-page":"524","article-title":"Nano-curcumin attenuates nephropathic lesions induced by chronic Ketoprofen Administration in Rats: role of Cyclooxygenase-1","volume":"12","author":"Ali","year":"2022","journal-title":"J. Adv. Vet. Res."},{"key":"10.1016\/j.intimp.2025.114486_bb0410","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3892\/etm_00000008","article-title":"Immunohistochemical expression of caspase-1 and -9, uncleaved caspase-3 and -6, cleaved caspase-3 and -6 as well as Bcl-2 in benign epithelium and cancer of the prostate","volume":"1","author":"Ummanni","year":"2010","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2025.114486_bb0415","doi-asserted-by":"crossref","DOI":"10.1186\/1756-9966-27-53","article-title":"NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues","volume":"27","author":"Meteoglu","year":"2008","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2025.114486_bb0420","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1039\/C8FO00653A","article-title":"Honey protects against cisplatin-induced hepatic and renal toxicity through inhibition of NF-\u03baB-mediated COX-2 expression and the oxidative stress dependent BAX\/Bcl-2\/caspase-3 apoptotic pathway","volume":"9","author":"Neamatallah","year":"2018","journal-title":"Food Funct."},{"key":"10.1016\/j.intimp.2025.114486_bb0425","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.toxlet.2018.03.023","article-title":"Resveratrol influences platinum pharmacokinetics: A novel mechanism in protection against cisplatin-induced nephrotoxicity","volume":"290","author":"Darwish","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.intimp.2025.114486_bb0430","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.2147\/DDDT.S249093","article-title":"Suppression of cisplatin-induced hepatic injury in rats through Alarmin high-mobility group Box-1 pathway by Ganoderma lucidum: theoretical and experimental study","volume":"14","author":"Hassan","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.intimp.2025.114486_bb0435","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.arcmed.2013.09.013","article-title":"Molsidomine prevents cisplatin-induced hepatotoxicity","volume":"44","author":"Bentli","year":"2013","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.intimp.2025.114486_bb0440","doi-asserted-by":"crossref","first-page":"3529149","DOI":"10.1155\/2016\/3529149","article-title":"Is liver enzyme release really associated with cell necrosis induced by oxidant stress?","volume":"2016","author":"Contreras-Zentella","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2025.114486_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112328","article-title":"The role of natural antioxidants in cisplatin-induced hepatotoxicity","volume":"144","author":"Abd Rashid","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2025.114486_bb0450","doi-asserted-by":"crossref","first-page":"10045","DOI":"10.1038\/s41598-023-35916-9","article-title":"Prophylactic consequences of sodium salicylate nanoparticles in cisplatin-mediated hepatotoxicity","volume":"13","author":"Alkhalaf","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2025.114486_bb0455","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071620","article-title":"Kinetin ameliorates cisplatin-induced hepatotoxicity and Lymphotoxicity via attenuating oxidative damage, cell apoptosis and inflammation in rats","volume":"10","author":"Fathy","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2025.114486_bb0460","doi-asserted-by":"crossref","first-page":"33774","DOI":"10.1007\/s11356-022-18626-z","article-title":"Centella asiatica extract protects against cisplatin-induced hepatotoxicity via targeting oxidative stress, inflammation, and apoptosis","volume":"29","author":"Ferah Okkay","year":"2022","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.intimp.2025.114486_bb0465","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/01480545.2023.2242008","article-title":"Effects of sodium hydrosulfide (NaHS) on cisplatin-induced hepatic and cardiac toxicity","volume":"47","author":"Mansouri","year":"2024","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.intimp.2025.114486_bb0470","first-page":"1246","article-title":"Polygonum minus essential oil modulates cisplatin-induced hepatotoxicity through inflammatory and apoptotic pathways","volume":"19","author":"Abd Rashid","year":"2020","journal-title":"EXCLI J."},{"key":"10.1016\/j.intimp.2025.114486_bb0475","article-title":"Calcium Dobesilate ameliorates cisplatin-induced hepatotoxicity by inhibiting liver oxidative stress in mice","volume":"22","author":"Bazmandegan","year":"2023","journal-title":"Iran. J. Pharm. Res. IJPR."},{"key":"10.1016\/j.intimp.2025.114486_bb0480","first-page":"1327","article-title":"Evaluation of the healing and protective properties of adipose-derived mesenchymal stem cells from cisplatin-induced liver and kidney damage","volume":"28","author":"\u00dcr\u00fcn","year":"2024","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2025.114486_bb0485","article-title":"Hepatoprotective effects of Alpinia officinarum rhizome extract on cisplatin-induced hepatotoxicity in rats: A biochemical, histopathological and immunohistochemical study","volume":"80","author":"Niazvand","year":"2023","journal-title":"J. Trace Elem. Med. Biol. Organ Soc. Miner. Trace Elem."},{"key":"10.1016\/j.intimp.2025.114486_bb0490","first-page":"897","article-title":"Alleviation of cisplatin-induced hepatotoxicity and nephrotoxicity by L-carnitine","volume":"25","author":"Hassan","year":"2022","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.intimp.2025.114486_bb0495","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ijcard.2015.04.248","article-title":"Rivaroxaban-induced liver injury: results from a venous thromboembolism registry","volume":"191","author":"Lambert","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.intimp.2025.114486_bb0500","first-page":"1683","article-title":"Symptomatic hepatocellular liver injury with hyperbilirubinemia in two patients treated with rivaroxaban, JAMA","volume":"174","author":"Liakoni","year":"2014","journal-title":"Intern. Med."},{"key":"10.1016\/j.intimp.2025.114486_bb0505","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1007\/s10620-014-3504-9","article-title":"Severe drug-induced skin and liver injury from rivaroxaban","volume":"60","author":"Barrett","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.intimp.2025.114486_bb0510","first-page":"173","article-title":"Organo-platinum complexes as antitumor agents (review)","volume":"2","author":"Hill","year":"1982","journal-title":"Anticancer Res."},{"key":"10.1016\/j.intimp.2025.114486_bb0515","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.bmt.1700980","article-title":"Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome","volume":"20","author":"Beyer","year":"1997","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.intimp.2025.114486_bb0520","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0270-9295(03)00089-5","article-title":"Cisplatin nephrotoxicity","volume":"23","author":"Arany","year":"2003","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.intimp.2025.114486_bb0525","doi-asserted-by":"crossref","first-page":"7434","DOI":"10.1038\/s41598-024-57300-x","article-title":"Cyclosporine-induced kidney damage was halted by sitagliptin and hesperidin via increasing Nrf2 and suppressing TNF-\u03b1, NF-\u03baB, and Bax","volume":"14","author":"Abd-Eldayem","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2025.114486_bb0530","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.7150\/ijbs.80775","article-title":"Mitophagy alleviates cisplatin-induced renal tubular epithelial cell ferroptosis through ROS\/HO-1\/GPX4 axis","volume":"19","author":"Lin","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2025.114486_bb0535","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1007\/s00210-023-02632-0","article-title":"Agomelatine on cisplatin-induced nephrotoxicity via oxidative stress and apoptosis., Naunyn. Schmiedebergs","volume":"396","author":"Dil","year":"2023","journal-title":"Arch. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114486_bb0540","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1038\/s41401-021-00620-9","article-title":"Natural products: potential treatments for cisplatin-induced nephrotoxicity","volume":"42","author":"Fang","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2025.114486_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.semnephrol.2023.151341","article-title":"Cisplatin nephrotoxicity: novel insights into mechanisms and preventative strategies","volume":"42","author":"Motwani","year":"2022","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.intimp.2025.114486_bb0550","series-title":"Oxidative Stress, and Inflammation in Mice., Antioxidants","article-title":"Pharmacological activation of Sirt1 ameliorates cisplatin-induced acute kidney injury by suppressing apoptosis","volume":"vol. 8","author":"Kim","year":"2019"},{"key":"10.1016\/j.intimp.2025.114486_bb0555","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13568-020-00993-w","article-title":"Kaempferol ameliorates cisplatin induced nephrotoxicity by modulating oxidative stress, inflammation and apoptosis via ERK and NF-\u03baB pathways","volume":"10","author":"Wang","year":"2020","journal-title":"AMB Express"},{"key":"10.1016\/j.intimp.2025.114486_bb0560","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/jphp.12990","article-title":"Oral deferiprone administration ameliorates cisplatin-induced nephrotoxicity in rats","volume":"70","author":"Makhdoumi","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114486_bb0565","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20020313","article-title":"Protective smell of hydrogen sulfide and polysulfide in cisplatin-induced nephrotoxicity","volume":"20","author":"Cao","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.114486_bb0570","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.freeradbiomed.2023.12.010","article-title":"Isorhamnetin alleviates cisplatin-induced acute kidney injury via enhancing fatty acid oxidation","volume":"212","author":"Wang","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2025.114486_bb0575","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s12011-023-03742-9","article-title":"Protective effect of platelet-rich plasma on cisplatin-induced nephrotoxicity in adult male albino rats: histological and Immunohistochemical study","volume":"202","author":"Kelada","year":"2024","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.intimp.2025.114486_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117097","article-title":"The protective role of Achyranthes aspera extract against cisplatin-induced nephrotoxicity by alleviating oxidative stress, inflammation, and PANoptosis","volume":"319","author":"Lin","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2025.114486_bb0585","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/1076029609340163","article-title":"Interpretation of benefit-risk of enoxaparin as comparator in the RECORD program: rivaroxaban oral tablets (10 milligrams) for use in prophylaxis in deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee replacement surgery","volume":"15","author":"Van Thiel","year":"2009","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.intimp.2025.114486_bb0590","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/ckj\/sfy133","article-title":"Anticoagulant-related nephropathy: systematic review and meta-analysis","volume":"12","author":"De Aquino Moura","year":"2019","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.intimp.2025.114486_bb0595","first-page":"169","article-title":"A case of rivaroxaban-associated acute tubulointerstitial nephritis","volume":"75","author":"Monahan","year":"2017","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.intimp.2025.114486_bb0600","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.thromres.2019.04.007","article-title":"Dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: A Danish nationwide cohort study","volume":"178","author":"Xing","year":"2019","journal-title":"Thromb. Res."},{"key":"10.1016\/j.intimp.2025.114486_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01155","article-title":"Interference with coagulation Cascade as a novel approach to counteract cisplatin-induced acute tubular necrosis; an experimental study in rats","volume":"9","author":"Ewees","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114486_bb0610","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11239-020-02123-6","article-title":"Role of rivaroxaban in sunitinib-induced renal injuries via inhibition of oxidative stress-induced apoptosis and inflammation through the tissue nacrosis factor-\u03b1 induced nuclear factor-\u03baappa B signaling pathway in rats","volume":"50","author":"Al-Harbi","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.intimp.2025.114486_bb0615","first-page":"853","article-title":"Preventive effect of nebivolol on contrast-induced nephropathy in rats","volume":"23","author":"Toprak","year":"2008","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. - Eur. Ren. Assoc."},{"key":"10.1016\/j.intimp.2025.114486_bb0620","first-page":"1717","article-title":"Evaluation of hepatoprotective effect of Nebivolol and sodium copper Chlorophyllin on CCL4-induced hepatotoxicity in mice","volume":"26","author":"Said","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2025.114486_bb0625","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-024-02990-3","article-title":"Nebivolol protects the liver against lipopolysaccharide-induced oxidative stress, inflammation, and endoplasmic reticulum-related apoptosis through chop and Bip\/GRP78 signaling, Naunyn","author":"Unal","year":"2024","journal-title":"Schmiedebergs. Arch. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114486_bb0630","series-title":"Hepatoprotective Potentials of Nebivolol and Aliskiren on Methotrexate Induced Liver Toxicity","first-page":"563","volume":"7","author":"Mohammad","year":"2010"},{"key":"10.1016\/j.intimp.2025.114486_bb0635","first-page":"245","article-title":"Nebivolol ameliorates hepatic ischemia\/reperfusion injury on liver but not on distant organs","volume":"28","author":"Ulger","year":"2015","journal-title":"J. Investig. Surg. Off. J. Acad. Surg. Res."},{"key":"10.1016\/j.intimp.2025.114486_bb0640","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/clc.21013","article-title":"Does nebivolol prevent contrast-induced nephropathy in humans?","volume":"35","author":"G\u00fcnebakmaz","year":"2012","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.intimp.2025.114486_bb0645","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.nephro.2016.01.011","article-title":"Recent advances in the treatment of renal diseases with nebivolol: A literature review","volume":"12","author":"Shamekhi Amiri","year":"2016","journal-title":"Nephrol. Ther."},{"key":"10.1016\/j.intimp.2025.114486_bb0650","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.953749","article-title":"Treatment with \u03b2-blocker nebivolol ameliorates oxidative stress and endothelial dysfunction in tenofovir-induced nephrotoxicity in rats","volume":"9","author":"Nascimento","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.intimp.2025.114486_bb0655","first-page":"1","article-title":"Animal study of anthracycline-induced cardiotoxicity and nephrotoxicity and evaluation of protective agents","volume":"3","author":"Shafik","year":"2011","journal-title":"Cancer Sci. Ther."},{"key":"10.1016\/j.intimp.2025.114486_bb0660","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.etap.2019.03.018","article-title":"Modulation of eNOS\/iNOS by nebivolol protects against cyclosporine A-mediated nephrotoxicity through targeting inflammatory and apoptotic pathways","volume":"69","author":"El-Sheikh","year":"2019","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114486_bb0665","first-page":"286","article-title":"Histological and biochemical study on the possible protective effect of Nebivolol on gentamicin induced nephrotoxicity in adult male albino rats","volume":"44","author":"Tawfeek","year":"2021","journal-title":"Egypt. J. Histol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692500476X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692500476X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T00:09:53Z","timestamp":1744502993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692500476X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":133,"alternative-id":["S156757692500476X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114486","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nebivolol rescued the liver and kidney from the coadministration of rivaroxaban and cisplatin by targeting inflammation, oxidative stress, and apoptosis in rats","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114486"}}